BioSpace News Archive

Flare Therapeutics Inc. today announced that the first patients have been dosed in the company’s phase 1 study to assess the safety and tolerability of FX-909, a first-in-class small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), a master regulator of the luminal lineage.

Innate Pharma SA released its 2024 financial calendar.

IRLAB Therapeutics IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January-September 2023.

Conference call with live webcast by Sequana Medical today at 03:00 pm CEST / 09:00 am EST

GeNeuro, a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases, announced a collaboration with Verily, an Alphabet precision health technology company, to investigate biomarkers related to activation of the proinflammatory HERV-W envelope protein in SARS-CoV-2 infection.

Macomics Ltd, a leader in macrophage drug discovery, announces that it has appointed Kevin Lee Ph.D., MBA at Independent Non-Executive Director.

Calliditas Therapeutics AB, announced seven abstract presentations, including a late-breaking poster presentation, highlighting additional analyses of the Phase 3 NefIgArd study at the upcoming American Society of Nephrology Kidney Week 2023 in Philadelphia, PA, November 1-5, 2023.

Sanofi has delivered the first medicines from its Global Health Unit’s not-for-profit Impact brand portfolio to the Republic of Djibouti.

Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, announced four poster presentations at the upcoming European Society of Gene and Cell Therapy taking place October 24-27, 2023, in Brussels, Belgium.

Theravance Biopharma, Inc. will report its third quarter 2023 financial results and provide a business update after market close on Tuesday, November 7, 2023.